Tweets
Multiplicative Adverse Effects of Social Determinants of Health in Lupus Nephritis: A Meta-analysis and Systematic Review
https://t.co/Wht67skbG2 https://t.co/D55phMfHGh
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
Imaging-Only Diagnosis of Giant Cell Arteritis Is Feasible
Positive findings with color Doppler ultrasound were enough to diagnose GCA accurately without need for confirmation with TAB, a prospective study indicated.
https://t.co/2b3y2OCENA https://t.co/4OOFo1hRCv
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
Featured BSR Abstracts
Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.
https://t.co/Km8alIyCIP https://t.co/8yYUldF0pw
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
Lower Limb Muscle Mass Influences Osteoarthritis Risk
The Rotterdam study shows that weight-bearing recreational physical activity caused more incident knee osteoarthritis (KOA), but mainly when there was low muscle mass.
https://t.co/N6JnJJgXgY https://t.co/hL7fK0DPWJ
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
Study of 187 Oligoarticular JIA pts - Remission was achieved w/ DMARDs in 65.8%; predictors of nonresponse (DMARD resistance) - Elevated CRP (> 1.1 mg/dL' OR 1.3) & and high JADAS-71 at Dx (> 15.8; OR 1.7) https://t.co/tuO7UsEfrL https://t.co/KGcdBtneQt
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
French insurance claims study of 12071 #PsA pts on biologics (2015-2021) found total of 367 serious infections (3%; IR 1.7/100PY). SIR risk significantly lower for new users of etanercept (wHR 0.72) & ustekinumab (wHR 0.57) (vs ADA new users https://t.co/CutqoxA05e https://t.co/OUCUbrKnFF
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
Long term F/U of T2T in BeST (early RA 153) & IMPROVED (UA 282) pts 12 & 20 yrs after, the majority of RA & UA pts were in DAS remission (91% LDAS, 68% remission), & w/ limited functional disability (mean HAQ 0.6-0.8). Xray progression was mild https://t.co/vcL8Mnv0Ty https://t.co/lPVbNipFng
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
#BSR Analysis of 1,362 pts starting 1st JAKi before EMA warnings on JAKi (1/23) showed 28% prev failed ≥3 bDMARDs & 80% met ≥1 EMA JAKi risk criteria -that included 1) age ≥65 2) incr CV risk; 3) current/past smoker; 4) prior cancer https://t.co/U3IaswZUyy https://t.co/m43RDAbpwP
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
Machine learning analysis of retrosp EHR data (3/20-9/22) on 2+ million showed COVID (5.3%) outcomes in #IMID pts not linked to DMARD or IMID Dx; but rather to age, unvaccinated, & comorbidities (Afib, CAD, CHF, CKD, COPD, CA, liver Dz) https://t.co/aMmJD5P9cc https://t.co/Yy9FuCvol4
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
SLE Faculty Panel Q&A
https://t.co/2OWlhfmKaP https://t.co/jx6MPDtojS
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
Complex Autoantibody Patterns in RA
https://t.co/WmaXmmP7dY https://t.co/4dFgFEZ84i
Dr. John Cush @RheumNow ( View Tweet )
2 years ago
NEJM: evolution of pyoderma gangrenosum skin lesions https://t.co/vsgQhsjY5q https://t.co/INrbTIc9kX
Links:
Dr. John Cush @RheumNow ( View Tweet )
2 years ago


